Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
64,967,756
-
Total 13F shares
-
19,877,308
-
Share change
-
+7,450,679
-
Total reported value
-
$93,682,000
-
Price per share
-
$4.77
-
Number of holders
-
29
-
Value change
-
+$36,395,969
-
Number of buys
-
17
-
Number of sells
-
26
Institutional Holders of Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) as of Q2 2022
As of 30 Jun 2022,
Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,877,308 shares.
The largest 10 holders included
Sofinnova Investments, Inc., VR Adviser, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Rock Springs Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., NEA Management Company, LLC, SPHERA FUNDS MANAGEMENT LTD., JANUS HENDERSON GROUP PLC, Laurion Capital Management LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.